A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

AVANT Immunotherapeutics

About Avant Immunotherapeutics:

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. AVANT is developing a broad portfolio of vaccines and immunotherapeutics addressing a wide range of applications including bacterial and viral diseases, cardiovascular diseases, biodefense and food safety. These include single dose, oral vaccines that protect against important disease causing agents, a novel, proprietary vaccine candidate for cholesterol management, and an immunotherapeutic to improve patient outcomes after cardiac surgery. Their strategy is to demonstrate proof of concept for their products before leveraging their value through partnerships.

Pipeline Chart for Avant Immunotherapeutics


Phase II TP10 Cardiac Surgery
Phase II CETi-I Cholesterol Management
Phase II CholeraGarde Cholera
Phase IITy800 Typhoid Fever
Phase IInjectable Anthrax Anthrax
Phase ITheraporeHIV

More on Avant

Home Page

Key Statistics fo Avant

Basic Chart for Avant

Analyst Opinion

Analysts Estimates

News for Avant

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.